INS and diabetes mellitus: Metabolic actions of HN comprise improved blood glucose and insulin sensitivity, as well as enhanced glucose transporter type 4 expression in rodent models of diabetes, highlighting its potential as therapeutic targets in metabolic diseases (Lee et al., 2015; Wu et al., 2021).